AI Software for Brain MRI Gets Expanded FDA Clearance for Multiple Sclerosis Assessment
Through AI technology, Neurophet AQUA now provides multiple sclerosis (MS) analysis with a combination of lesion quantification and enhanced segmentation of T2-FLAIR MRI.
